Get The Daily Rip

Stocktwits Top 25 – Week 38 πŸ“‰

Welcome to the Stocktwits Top 25 Newsletter for Week 38 of 2023!

The Stocktwits Top 25 reports the 25 best-performing stocks in the S&P 500, Nasdaq 100, and Russell 2000 year to date (YTD) and tracks their performances over time.Β 

Here are the Stocktwits Top 25 Lists for Week 38:

P.S. To help you understand this data further, check out our FAQ page, and feel free to reach out if you have questions!

Standard and Poor's 500

ST Top 25 S&P 500

The S&P 500 Top 25 list (-3.65%) underperformed the S&P 500 index (-2.93%).

There were two major changes to the list this week.

Joining: FedEx Corp (+2.76%) and Lam Research Corp (-0.64%).

Leaving: Align Technology (-10.10%) and ServiceNow (-4.40%).

Check out how the momentum meter has performed vs. the S&P 500 index this year:


The Large-Cap Nasdaq 100

The Nasdaq 100 Top 25 list (-4.05%) underperformed the Nasdaq 100 index (-3.30%).

There was one majorΒ changeΒ to the list this week.

Synopsys Inc (-1.12%) replaced Workday (-4.17%) on the list.


The Growth-Centric Russell 2000

The Russell 2000 Top 25 list (-5.48%) underperformed the Russell 2000 index (-3.82%).

There were three major changes to the list this week.

Joining: Mimedx Group (+0.53%), Cimpress PLC (+4.45%), and Innodata (-2.65%).

Leaving: Cardlytics (-24.80%), Eyepoint Pharmaceuticals (-19.37%), and Marathon Digital (-11.53%).



The Top 25 lists’ Top Dawg was Inozyne Pharma, which rallied 6.98%. πŸ“ˆ

There was not any specific news about the small-cap clinical-stage biopharmaceutical company driving this move. It looks to be benefitting from continued investor interest in micro and small-cap biotech companies. 🀷

The company will host a virtual investor and analyst event on September 26, 2023, which could move the stock. πŸ“

$INZY is up 338.10% YTD.

See Y’all Next Week πŸ€™